Medical Equipment

Drug Screening Market Dynamics 2026: Future Outlook and Key Insights

February 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Drug Screening Market size between 2026 and 2035?

The drug screening market size has expanded significantly in recent times. It is anticipated to increase from $9.72 billion in 2025 to $11.18 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.0%. Historically, this growth can be linked to the rise in workplace drug testing programs, the expansion of clinical trial activities, increasing law enforcement screening requirements, the proliferation of diagnostic laboratories, and improved availability of rapid test kits.

The drug screening market size is projected to experience substantial growth in the upcoming years. It is forecast to expand to $19.2 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.5%. This anticipated growth during the forecast period is primarily due to factors such as the increasing adoption of AI-enabled screening analytics, a rising demand for portable drug testing devices, the expansion of regulatory drug compliance testing, the growing use of real-time reporting systems, and innovation in multi-panel drug screening. Major trends identified for the forecast period encompass the increasing adoption of rapid drug testing kits, the rising use of automated laboratory screening systems, the growing integration of digital reporting solutions, the expansion of point-of-care drug testing, and an enhanced focus on high-accuracy detection.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6369&type=smp

Which Drivers Are Impacting Market Performance In The Drug Screening Market?

Increasing drug and alcohol consumption is anticipated to propel the expansion of the drug screening market in the future. Drug addiction is defined as a condition affecting an individual’s brain and behavior, leading to an inability to control the use of legal or illegal substances or medications. Substances such as alcohol, marijuana, and nicotine are also categorized as drugs. As addiction to drugs and alcohol rises, the likelihood of diseases also increases, thereby stimulating the demand for drug screening. For instance, in June 2025, the United Nations Office on Drugs and Crime, an Austria-based United Nations office, reported that 316 million people, or six percent of the population aged between 15 and 64, used a drug (excluding alcohol and tobacco) in 2023. Cannabis remained the most widely used drug with 244 million users, followed by opioids (61 million), amphetamines (30.7 million), cocaine (25 million), and “ecstasy” (21 million). Consequently, the rising consumption of drugs and alcohol is driving the growth of the drug screening market during the forecast period.

Which Segments Are Contributing To The Growth Of The Drug Screening Market?

The drug screening market covered in this report is segmented –

1) By Products: Rapid Testing Devices, Consumables, Other Products

2) By Sample Type: Oral Fluid Sample, Hair Sample, Urine Sample, Breath Sample, Other Sample Types

3) By End User: Drug Testing Laboratories, Workplaces, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges

Subsegments:

1) By Rapid Testing Devices: Urine Drug Test Kits, Saliva Drug Test Kits, Blood Drug Test Devices, Instant Test Strips

2) By Consumables: Reagents and Assays, Sample Collection Devices, Calibration Standards

3) By Other Products: Laboratory Equipment, Software Solutions, Storage and Transport Solutions

What Trends Are Projected To Support The Growth Of The Drug Screening Market?

Leading companies in the drug screening market are increasingly concentrating on strategic alliances and cooperative ventures to bolster their financial strength, expand their product offerings, and extend their global footprint. A strategic collaboration signifies an agreement between two or more entities to pursue a defined set of objectives while maintaining their independent organizational structures. For example, in February 2025, Neopharma Technologies, a Canada-based drug testing firm, and Impairment Science, a United States-based cognitive assessment company, announced a strategic partnership aimed at transforming drug and impairment testing. This collaboration merges Neopharma’s NEOVAULT platform, which provides digital reading and reporting of rapid drug test results, with Impairment Science’s DRUID cognitive impairment assessment, an AI-driven tool for evaluating functional impairment. By integrating these two distinct technologies, the partnership endeavors to enhance the accuracy and relevance of drug screening, delivering real-time insights not only regarding drug presence but also functional impairment. This cooperative effort, by utilizing AI and digital reporting technologies, holds the potential to improve workplace safety, ensure better regulatory compliance, and facilitate more informed safety-sensitive decision-making.

Who Are The Top-Performing Companies In The Drug Screening Market In Recent Years?

Major companies operating in the drug screening market are Laboratory Corporation, Quest Diagnostics Incorporated, OraSure Technologies Inc., Alfa Scientific Designs Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, LifeLoc Technologies Inc., MPD Inc., Omega Laboratories Inc., Premier Biotech Inc., Psychemedics Corporation, F. Hoffmann-La Roche Ltd., Shimadzu Corporation, Siemens Healthineers AG, Medtox Scientific Inc., American Screening Corporation, Clinical Reference Laboratory Inc., Express Diagnostics International Inc., Global Drug Testing Services, Kroll Laboratory Specialists Inc., Medscreen Laboratories, National Screening Centers Inc., American Bio Medica Corporation, Mayo Clinic Laboratories, ACM Global Laboratories, Intertek Group plc, Eurofins Scientific SE

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Drug Screening Market?

North America was the largest region in the drug screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug screening market during the forecast period. The regions covered in the drug screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Screening Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=6369&type=smp

Browse Through More Reports Similar to the Global Drug Screening Market 2026, By The Business Research Company

Pharmaceuticals Market 2026

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Drug Discovery Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Pharmaceutical Label Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmaceutical-label-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795